Literature DB >> 19768570

Prevalence of classical phenylketonuria in mentally retarded individuals in Iran.

N M Ghiasvand1, A Aledavood, R Ghiasvand, F Seyedin Borojeny, A R Aledavood, S Seyed, W Miner, G R Saeb Taheri.   

Abstract

Using Guthrie Biological Inhibition Assay, 4963 mentally retarded individuals housed in 31 cities and towns across the country were screened for PKU. The average prevalence of classical PKU in the study population was 2.1%, which is higher than that reported for most mentally retarded populations in other countries prior to the implementation of a nationwide newborn screening programme for PKU. The prevalence of PKU in 1814 mentally retarded inmates housed in shelters in Tehran was 2.81%, and the prevalence of the disease in 3149 inmates sheltered in other cities and towns was 1.68%. It appears that most of the difference between the prevalence of PKU in these two populations is due to a unique PKU referral pattern in Iran. The high prevalence of PKU in the mentally retarded population in Iran could be indicative of a high incidence of the disease among Iranian neonates. This in turn appears to be positively influenced by both a high frequency of the PKU allele and a high rate of consanguinity in the country. Our finding suggests that instead of limited local screening programmes in the country, a nationwide screening programme for PKU, especially if coupled with screening for congenital hypothyroidism, would be highly cost-effective and warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19768570     DOI: 10.1007/s10545-009-1222-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  Incidence of phenylketonuria in Iran estimated from consanguineous marriages.

Authors:  J Koochmeshgi; A Bagheri; S M Hosseini-Mazinani
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

2.  Incidence and distribution of pku-cases in Denmark.

Authors:  E Wamberg
Journal:  Ir Med J       Date:  1976-09-30

3.  Phenylalanine hydroxylase expression in liver of a fetus with phenylketonuria.

Authors:  F D Ledley; R Koch; K Jew; A Beaudet; W E O'Brien; D P Bartos; S L Woo
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

4.  PKU program in Illinois. A 10 year study.

Authors:  J P Paulissen; M Zeldes
Journal:  IMJ Ill Med J       Date:  1971-12

5.  A survey for the incidence of phenylketonuria in Guangdong, China.

Authors:  Jianhui Jiang; Xieqin Ma; Xiaochun Huang; Xinyan Pei; Haipin Liu; Zhiwei Tan; Lanfang Zhu
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003       Impact factor: 0.267

6.  Phenylketonuria in Iranian population: a study in institutions for mentally retarded in Isfahan.

Authors:  Sadeq Vallian; Elham Barahimi; Hasan Moeini
Journal:  Mutat Res       Date:  2003-05-15       Impact factor: 2.433

7.  The frequency of PKU and hyperphenylalaninemia in Sweden - a study in institutions for the mentally retarded as well as in neonates.

Authors:  G Holmgren; A Larsson; H Palmstierna; J Alm
Journal:  Clin Genet       Date:  1976-12       Impact factor: 4.438

8.  Phenylketonuria in Kuwait and Arab countries.

Authors:  A S Teebi; S A Al-Awadi; T I Farag; K K Naguib; M Y el-Khalifa
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

9.  Phenylalanine metabolites, attention span and hyperactivity.

Authors:  K Michals; R Matalon
Journal:  Am J Clin Nutr       Date:  1985-08       Impact factor: 7.045

10.  Incidence of phenylketonuria (PKU) in Iran.

Authors:  D D Farhud; M Kabiri
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

View more
  4 in total

1.  A novel compound-primed multiplex ARMS-PCR (CPMAP) for simultaneous detection of common PAH gene mutations.

Authors:  Maryam Shaykholeslam Esfahani; Ehsan Shaykholeslam Esfahani; Sadeq Vallian
Journal:  Metab Brain Dis       Date:  2018-04-03       Impact factor: 3.584

2.  Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses.

Authors:  Filipa Ferreira; Luísa Azevedo; Raquel Neiva; Carmen Sousa; Helena Fonseca; Ana Marcão; Hugo Rocha; Célia Carmona; Sónia Ramos; Anabela Bandeira; Esmeralda Martins; Teresa Campos; Esmeralda Rodrigues; Paula Garcia; Luísa Diogo; Ana Cristina Ferreira; Silvia Sequeira; Francisco Silva; Luísa Rodrigues; Ana Gaspar; Patrícia Janeiro; António Amorim; Laura Vilarinho
Journal:  Mol Genet Genomic Med       Date:  2021-01-19       Impact factor: 2.183

3.  Phenylketonuria screening and management in southeastern Europe - survey results from 11 countries.

Authors:  Mojca Zerjav Tansek; Urh Groselj; Natalija Angelkova; Dana Anton; Ivo Baric; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Miljanovic; Florentina Moldovanu; Mariana Muresan; Michaela Nanu; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

Review 4.  The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review.

Authors:  Ashraf El-Metwally; Lujane Yousef Al-Ahaidib; Alaa Ayman Sunqurah; Khaled Al-Surimi; Mowafa Househ; Ali Alshehri; Omar B Da'ar; Hira Abdul Razzak; Ali Nasser AlOdaib
Journal:  Biomed Res Int       Date:  2018-04-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.